| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GEO2 On April 23, 2019 the Food and Drug Administration updated their ban on the import of all germanium-containing products that are promoted as drugs or dietary supplements for human consumption. The banned list includes but is not restricted to:Germanium Sesquioxide GE-132 GE-OXY-132 Vitamin “O”” Pro-Oxygen Nutrigel 132 Immune Multiple Germax Inorganic germanium — comprises elemental germanium and carbon-free germanium compounds, with germanium dioxide as the principal orally investigated toxic form. Germanium dioxide, abbreviated GeO₂ and also called germania or germanium oxide, is an inorganic oxide of tetravalent germanium. Germanium is a nonessential trace element and has no established nutritional requirement. GeO₂ is used primarily as an industrial material in glass, optical, ceramic and semiconductor applications; it is not an approved therapeutic agent or dietary nutrient. Its limited experimental anticancer findings occur at millimolar concentrations and are outweighed by well-documented renal toxicity after prolonged systemic exposure. Primary mechanisms (ranked):
Bioavailability / PK relevance: Absorbed inorganic germanium is substantially cleared through the kidneys, but repeated GeO₂ exposure can produce tissue retention, particularly in kidney and peripheral nerve. Animal studies report a longer residence time in kidney than in plasma and progressive accumulation during repeated administration. Renal impairment may further reduce elimination and amplify tissue exposure. In-vitro vs systemic exposure relevance: The reported cell-cycle and radiosensitizing effects generally required millimolar GeO₂ concentrations, including approximately 1–5 mM exposures. These concentrations are not supported as safely achievable systemic anticancer exposures. The effects were demonstrated largely in Chinese hamster ovary cells rather than validated human cancer models and were not tumor-selective. Clinical evidence status: Preclinical only for anticancer activity. No credible clinical evidence supports inorganic germanium or GeO₂ as cancer treatment or adjunct therapy. Human evidence instead consists primarily of poisoning cases involving chronic renal failure, anemia, muscular injury and neurological complications. GeO₂ has no approved oncology indication, and germanium-containing ingestible products remain subject to significant regulatory safety restrictions. Inorganic Germanium Mechanistic Profile
P: 0–30 min R: 30 min–3 hr G: >3 hr |
| Source: |
| Type: |
| Caspases are a cysteine protease that speed up a chemical reaction via pointing their target substrates following an aspartic acid residue.1 They are grouped into apoptotic (caspase-2, 3, 6, 7, 8, 9 and 10) and inflammatory (caspase-1, 4, 5, 11 and 12) mediated caspases. Caspase-1 may have both tumorigenic or antitumorigenic effects on cancer development and progression, but it depends on the type of inflammasome, methodology, and cancer. Catalase is an enzyme found in nearly all living cells exposed to oxygen. Its primary role is to protect cells from oxidative damage by catalyzing the conversion of hydrogen peroxide (H₂O₂), a potentially damaging byproduct of metabolism, into water (H₂O) and oxygen (O₂). This detoxification process is crucial because excess H₂O₂ can lead to the formation of reactive oxygen species (ROS) that damage proteins, lipids, and DNA. Catalase and Cancer Oxidative Stress and Cancer: Cancer cells often experience increased levels of oxidative stress due to rapid proliferation and metabolic changes. This stress can lead to DNA damage, promoting tumorigenesis. Catalase helps mitigate oxidative stress, and its expression can influence the survival and proliferation of cancer cells. Expression Levels in Different Cancers: Overexpression: In some cancers, such as breast cancer and certain types of leukemia, catalase may be overexpressed. This overexpression can help cancer cells survive in oxidative environments, potentially leading to more aggressive tumor behavior. Downregulation: Conversely, in other cancers, such as colorectal cancer, reduced catalase expression has been observed. This downregulation can lead to increased oxidative stress, contributing to tumor progression and metastasis. Prognostic Implications: Survival Rates: Studies have shown that high levels of catalase expression can be associated with poor prognosis in certain cancers, as it may enable cancer cells to resist apoptosis (programmed cell death) induced by oxidative stress. Some types of cancer cells have been reported to exhibit lower catalase activity, possibly increasing their vulnerability to oxidative damage under certain conditions. This vulnerability has even been exploited in some therapeutic strategies (for example, approaches that generate excess H₂O₂ or other ROS specifically targeting cancer cells have been researched). |
| 7119- | GEO2, | Germanium oxide enhances the radiosensitivity of cells |
| - | in-vitro, | Nor, | CHO K1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:87 Target#:46 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid